8-K
Current Report
Aclaris Therapeutics, Inc. Filed Acc 0001558370-22-011475
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading acrs-20220801x8k.htm…